Publications by authors named "Roseline Re"

Claim this Profile
A
Advanced Hybrid Closed Loop in Adult Population With Type 1 Diabetes: A Substudy From the ADAPT Randomized Controlled Trial in Users of Real-Time Continuous Glucose Monitoring.
Tim van den Heuvel, Ralf Kolassa, Winfried Keuthage, Jens Kroeger, Roseline Ré

J Diabetes Sci Technol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Automated Insulin Delivery System with Automatic Meal Bolus Based on a Hand-Gesturing Algorithm.
Anirban Roy, Benyamin Grosman, Andrea Benedetti, Bahman Engheta, Diana Miller

Diabetes Technol Ther· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Twelve-month results of the ADAPT randomized controlled trial: Reproducibility and sustainability of advanced hybrid closed-loop therapy outcomes versus conventional therapy in adults with type 1 diabetes.
Shannon N Edd, Javier Castañeda, Pratik Choudhary, Ralf Kolassa, Winfried Keuthage

Diabetes Obes Metab· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advanced hybrid closed loop therapy versus conventional treatment in adults with type 1 diabetes (ADAPT): a randomised controlled study.
Pratik Choudhary, Ralf Kolassa, Winfried Keuthage, Jens Kroeger, Charles Thivolet

Lancet Diabetes Endocrinol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomised controlled trial of Advanced Hybrid Closed Loop in an Adult Population with Type 1 Diabetes (ADAPT): study protocol and rationale.
Simona de Portu, Linda Vorrink, Roseline Re, John Shin, Javier Castaneda

BMJ Open· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial.
Emanuele Bosi, Pratik Choudhary, Harold W de Valk, Sandrine Lablanche, Javier Castañeda

Lancet Diabetes Endocrinol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis